Headline
The latest stories from AHA Today.
The Food and Drug Administration authorized administering the monoclonal antibodies bamlanivimab and etesevimab together to prevent COVID-19 in certain children and adults exposed to SARS-CoV-2 who are not fully vaccinated against COVID-19 and at high-risk for progressing to severe disease.
The Food and Drug Administration alerted clinical laboratory staff and health care providers to the potential for false positive results with two test kits made by Abbott Molecular to detect SARS-CoV-2.
Pfizer released the first data evaluating a COVID-19 vaccine’s safety and effectiveness for children between the ages of 5 and 11.
The Centers for Medicare & Medicaid Services released a final rule with additional policies for health insurance issuers and the Health Insurance Marketplaces for plan years 2022 and beyond.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee by a unanimous vote recommended that the FDA issue an emergency use authorization that would enable COVID-19 vaccine boosters for individuals age 65 and older and those at high risk for severe COVID-19,…
Percy Allen II, past president of the National Association of Health Services Executives, died Sept. 12 at age 80. Among other leadership positions, he served as assistant administrator at Parkview Memorial Hospital in Ft. Wayne, Ind.; CEO at North Central Bronx Hospital in New York; vice president…
The AHA and its Institute for Diversity and Health Equity are now accepting applications for the 2022 Carolyn Boone Lewis Equity of Care Awards. The awards recognize hospitals and health systems that are proactive in advancing diversity, health equity and equitable health care through data,…
Rep. Haley Stevens, D-Mich., and Sen. Debbie Stabenow, D-Mich., introduced a bicameral resolution designating Sept. 17 as National Physician Suicide Awareness Day.
The Centers for Disease Control and Prevention revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna’s vaccine deemed most effective at preventing hospitalizations.
The Health Resources and Services Administration awarded $342 million to expand home visiting services to pregnant women and parents with young children in U.S. states and territories.